Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

SPDR® S&P Biotech ETF (XBI)

Delayed Data
As of Aug 26
 +0.71 / +1.18%
Today’s Change
Today|||52-Week Range

Investment Objective

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Biotechnology Select Industry Index derived from the biotechnology segment of a U.S. total market composite index. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology industry group of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.


1 month+1.97% 3 years+15.23%
3 months+8.86% 5 years+25.53%
1 year-15.79% Since inception+13.60%
Data through 08/27/2016

Quote Details

Previous close$60.39
Open day’s range60.17 – 61.76
Net asset value (NAV)61.09 (08/26/2016)
Daily volume10,098,289
Average volume (3 months)7,166,615
Data as of 3:59pm ET, 08/26/2016

Peer Comparisonvs. Health ETFs

Performance 5-yr return+25.53%+15.32%
Expense Gross exp ratio0.35%0.47%
Risk 5 year sharpe ratio0.801.12
Net assets$2.2B$1.2B
Average market cap$4.7B$31.2B
Average P/E--18.7
Dividend / Share--0.22%


XLV Health Care Select Sector SPDR® Fund
RYH Guggenheim S&P 500® Equal Weight Health...
VHT Vanguard Health Care Index Fund ETF Shar...


Top 5 Sectors
Portfolio weighting
Healthcare 100.00%
Business service 0.00%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
IONS Ionis Pharmaceuticals Inc2.94%
SRPT Sarepta Therapeutics Inc2.78%
BLUE bluebird bio Inc2.77%
BMRN Biomarin Pharmaceutical Inc2.69%
BIIB Biogen2.58%
ALKS Alkermes Plc2.56%
ICPT Intercept Pharmaceuticals Inc2.52%
REGN Regeneron Pharmaceuticals2.51%
INCY Incyte Corp2.46%

Partner Offers

Search for Jobs